Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer.

Gollob JA, Rathmell WK, Richmond TM, Marino CB, Miller EK, Grigson G, Watkins C, Gu L, Peterson BL, Wright JJ
J Clin Oncol. 2007 25 (22): 3288-95

PMID: 17664476 · DOI:10.1200/JCO.2007.10.8613

MeSH Terms (22)

Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Benzenesulfonates Carcinoma, Renal Cell Female Humans Interferon-alpha Interferon alpha-2 Kidney Neoplasms Magnetic Resonance Imaging Male Middle Aged Niacinamide North Carolina Phenylurea Compounds Pyridines Recombinant Proteins Sorafenib Tomography, X-Ray Computed Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: